nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—Tamoxifen—pancreatic cancer	0.102	0.115	CbGbCtD
Methimazole—CYP2E1—Dacarbazine—pancreatic cancer	0.0843	0.0956	CbGbCtD
Methimazole—CYP2A6—Fluorouracil—pancreatic cancer	0.0749	0.085	CbGbCtD
Methimazole—CYP2E1—Tamoxifen—pancreatic cancer	0.0671	0.0761	CbGbCtD
Methimazole—CYP2B6—Tamoxifen—pancreatic cancer	0.0661	0.0751	CbGbCtD
Methimazole—CYP2B6—Irinotecan—pancreatic cancer	0.0508	0.0576	CbGbCtD
Methimazole—CYP1A2—Dacarbazine—pancreatic cancer	0.0487	0.0553	CbGbCtD
Methimazole—CYP2C19—Tamoxifen—pancreatic cancer	0.042	0.0477	CbGbCtD
Methimazole—CYP1A2—Tamoxifen—pancreatic cancer	0.0388	0.044	CbGbCtD
Methimazole—CYP2C9—Tamoxifen—pancreatic cancer	0.0349	0.0396	CbGbCtD
Methimazole—CYP1A2—Erlotinib—pancreatic cancer	0.033	0.0374	CbGbCtD
Methimazole—CYP2D6—Tamoxifen—pancreatic cancer	0.032	0.0363	CbGbCtD
Methimazole—CYP1A2—Fluorouracil—pancreatic cancer	0.0286	0.0324	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—pancreatic cancer	0.0277	0.0315	CbGbCtD
Methimazole—CYP2D6—Erlotinib—pancreatic cancer	0.0272	0.0308	CbGbCtD
Methimazole—CYP2C9—Fluorouracil—pancreatic cancer	0.0257	0.0292	CbGbCtD
Methimazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0203	0.0231	CbGbCtD
Methimazole—CYP3A4—Erlotinib—pancreatic cancer	0.0173	0.0196	CbGbCtD
Methimazole—CYP3A4—Irinotecan—pancreatic cancer	0.0156	0.0177	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—pancreatic cancer	0.0134	0.0152	CbGbCtD
Methimazole—CYP3A4—Docetaxel—pancreatic cancer	0.0114	0.013	CbGbCtD
Methimazole—CYP3A4—Sunitinib—pancreatic cancer	0.0114	0.0129	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00852	0.00967	CbGbCtD
Methimazole—Nephritis—Erlotinib—pancreatic cancer	0.00672	0.0566	CcSEcCtD
Methimazole—Pigmentation disorder—Sunitinib—pancreatic cancer	0.00596	0.0502	CcSEcCtD
Methimazole—Drug fever—Docetaxel—pancreatic cancer	0.00339	0.0286	CcSEcCtD
Methimazole—Ageusia—Sunitinib—pancreatic cancer	0.00245	0.0207	CcSEcCtD
Methimazole—Pigmentation disorder—Epirubicin—pancreatic cancer	0.00229	0.0193	CcSEcCtD
Methimazole—Neuritis—Gemcitabine—pancreatic cancer	0.00214	0.018	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—pancreatic cancer	0.00212	0.0178	CcSEcCtD
Methimazole—Neuritis—Docetaxel—pancreatic cancer	0.00152	0.0128	CcSEcCtD
Methimazole—Ageusia—Docetaxel—pancreatic cancer	0.0014	0.0118	CcSEcCtD
Methimazole—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.00126	0.0106	CcSEcCtD
Methimazole—Hepatitis—Tamoxifen—pancreatic cancer	0.00117	0.00982	CcSEcCtD
Methimazole—Hepatitis—Erlotinib—pancreatic cancer	0.00115	0.00971	CcSEcCtD
Methimazole—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.00109	0.00918	CcSEcCtD
Methimazole—Alopecia—Tamoxifen—pancreatic cancer	0.00103	0.00867	CcSEcCtD
Methimazole—Neuritis—Epirubicin—pancreatic cancer	0.00102	0.00861	CcSEcCtD
Methimazole—Alopecia—Erlotinib—pancreatic cancer	0.00102	0.00858	CcSEcCtD
Methimazole—Hepatitis—Sunitinib—pancreatic cancer	0.000998	0.00841	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—pancreatic cancer	0.000946	0.00797	CcSEcCtD
Methimazole—Ageusia—Epirubicin—pancreatic cancer	0.000942	0.00794	CcSEcCtD
Methimazole—Leukopenia—Tamoxifen—pancreatic cancer	0.000908	0.00765	CcSEcCtD
Methimazole—Jaundice—Irinotecan—pancreatic cancer	0.000893	0.00752	CcSEcCtD
Methimazole—Alopecia—Sunitinib—pancreatic cancer	0.000882	0.00743	CcSEcCtD
Methimazole—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.000875	0.00737	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—pancreatic cancer	0.000872	0.00734	CcSEcCtD
Methimazole—Arthralgia—Tamoxifen—pancreatic cancer	0.000864	0.00728	CcSEcCtD
Methimazole—Myalgia—Tamoxifen—pancreatic cancer	0.000864	0.00728	CcSEcCtD
Methimazole—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00086	0.00724	CcSEcCtD
Methimazole—Arthralgia—Erlotinib—pancreatic cancer	0.000855	0.0072	CcSEcCtD
Methimazole—Myalgia—Erlotinib—pancreatic cancer	0.000855	0.0072	CcSEcCtD
Methimazole—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000833	0.00701	CcSEcCtD
Methimazole—Oedema—Tamoxifen—pancreatic cancer	0.000828	0.00697	CcSEcCtD
Methimazole—Oedema—Erlotinib—pancreatic cancer	0.000819	0.0069	CcSEcCtD
Methimazole—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000819	0.0069	CcSEcCtD
Methimazole—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000811	0.00683	CcSEcCtD
Methimazole—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000802	0.00676	CcSEcCtD
Methimazole—Leukopenia—Sunitinib—pancreatic cancer	0.000778	0.00655	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000754	0.00635	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000746	0.00629	CcSEcCtD
Methimazole—Paraesthesia—Tamoxifen—pancreatic cancer	0.000744	0.00626	CcSEcCtD
Methimazole—Myalgia—Sunitinib—pancreatic cancer	0.00074	0.00623	CcSEcCtD
Methimazole—Arthralgia—Sunitinib—pancreatic cancer	0.00074	0.00623	CcSEcCtD
Methimazole—Dyspepsia—Tamoxifen—pancreatic cancer	0.000729	0.00614	CcSEcCtD
Methimazole—Alopecia—Irinotecan—pancreatic cancer	0.000727	0.00612	CcSEcCtD
Methimazole—Dyspepsia—Erlotinib—pancreatic cancer	0.000721	0.00607	CcSEcCtD
Methimazole—Aplastic anaemia—Epirubicin—pancreatic cancer	0.000717	0.00604	CcSEcCtD
Methimazole—Oedema—Sunitinib—pancreatic cancer	0.000709	0.00597	CcSEcCtD
Methimazole—Alopecia—Gemcitabine—pancreatic cancer	0.000708	0.00596	CcSEcCtD
Methimazole—Alopecia—Fluorouracil—pancreatic cancer	0.000696	0.00586	CcSEcCtD
Methimazole—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000694	0.00585	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000663	0.00559	CcSEcCtD
Methimazole—Urticaria—Tamoxifen—pancreatic cancer	0.000658	0.00554	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—pancreatic cancer	0.00065	0.00547	CcSEcCtD
Methimazole—Body temperature increased—Erlotinib—pancreatic cancer	0.000648	0.00545	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000646	0.00544	CcSEcCtD
Methimazole—Vertigo—Irinotecan—pancreatic cancer	0.000643	0.00542	CcSEcCtD
Methimazole—Leukopenia—Irinotecan—pancreatic cancer	0.000641	0.0054	CcSEcCtD
Methimazole—Paraesthesia—Sunitinib—pancreatic cancer	0.000637	0.00536	CcSEcCtD
Methimazole—Dyspepsia—Sunitinib—pancreatic cancer	0.000624	0.00526	CcSEcCtD
Methimazole—Leukopenia—Gemcitabine—pancreatic cancer	0.000624	0.00526	CcSEcCtD
Methimazole—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000621	0.00523	CcSEcCtD
Methimazole—Jaundice—Docetaxel—pancreatic cancer	0.000617	0.0052	CcSEcCtD
Methimazole—Leukopenia—Fluorouracil—pancreatic cancer	0.000614	0.00517	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.000601	0.00506	CcSEcCtD
Methimazole—Arthralgia—Gemcitabine—pancreatic cancer	0.000594	0.005	CcSEcCtD
Methimazole—Myalgia—Gemcitabine—pancreatic cancer	0.000594	0.005	CcSEcCtD
Methimazole—Agranulocytosis—Docetaxel—pancreatic cancer	0.000591	0.00498	CcSEcCtD
Methimazole—Pruritus—Tamoxifen—pancreatic cancer	0.000586	0.00493	CcSEcCtD
Methimazole—Oedema—Irinotecan—pancreatic cancer	0.000584	0.00492	CcSEcCtD
Methimazole—Myalgia—Fluorouracil—pancreatic cancer	0.000584	0.00492	CcSEcCtD
Methimazole—Pruritus—Erlotinib—pancreatic cancer	0.00058	0.00488	CcSEcCtD
Methimazole—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000572	0.00482	CcSEcCtD
Methimazole—Oedema—Gemcitabine—pancreatic cancer	0.000569	0.00479	CcSEcCtD
Methimazole—Hepatitis—Docetaxel—pancreatic cancer	0.000568	0.00479	CcSEcCtD
Methimazole—Body temperature increased—Sunitinib—pancreatic cancer	0.000561	0.00472	CcSEcCtD
Methimazole—Oedema—Fluorouracil—pancreatic cancer	0.000559	0.00471	CcSEcCtD
Methimazole—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000557	0.00469	CcSEcCtD
Methimazole—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000548	0.00461	CcSEcCtD
Methimazole—Vomiting—Tamoxifen—pancreatic cancer	0.000526	0.00443	CcSEcCtD
Methimazole—Paraesthesia—Irinotecan—pancreatic cancer	0.000525	0.00442	CcSEcCtD
Methimazole—Rash—Tamoxifen—pancreatic cancer	0.000522	0.0044	CcSEcCtD
Methimazole—Dermatitis—Tamoxifen—pancreatic cancer	0.000522	0.00439	CcSEcCtD
Methimazole—Vomiting—Erlotinib—pancreatic cancer	0.000521	0.00439	CcSEcCtD
Methimazole—Somnolence—Irinotecan—pancreatic cancer	0.000519	0.00437	CcSEcCtD
Methimazole—Headache—Tamoxifen—pancreatic cancer	0.000519	0.00437	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000518	0.00437	CcSEcCtD
Methimazole—Rash—Erlotinib—pancreatic cancer	0.000517	0.00435	CcSEcCtD
Methimazole—Dermatitis—Erlotinib—pancreatic cancer	0.000516	0.00435	CcSEcCtD
Methimazole—Dyspepsia—Irinotecan—pancreatic cancer	0.000514	0.00433	CcSEcCtD
Methimazole—Headache—Erlotinib—pancreatic cancer	0.000513	0.00432	CcSEcCtD
Methimazole—Paraesthesia—Gemcitabine—pancreatic cancer	0.000511	0.0043	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00051	0.00429	CcSEcCtD
Methimazole—Somnolence—Gemcitabine—pancreatic cancer	0.000506	0.00426	CcSEcCtD
Methimazole—Paraesthesia—Fluorouracil—pancreatic cancer	0.000502	0.00423	CcSEcCtD
Methimazole—Alopecia—Docetaxel—pancreatic cancer	0.000502	0.00423	CcSEcCtD
Methimazole—Pruritus—Sunitinib—pancreatic cancer	0.000502	0.00423	CcSEcCtD
Methimazole—Somnolence—Fluorouracil—pancreatic cancer	0.000497	0.00419	CcSEcCtD
Methimazole—Dyspepsia—Fluorouracil—pancreatic cancer	0.000492	0.00415	CcSEcCtD
Methimazole—Nausea—Tamoxifen—pancreatic cancer	0.000492	0.00414	CcSEcCtD
Methimazole—Nausea—Erlotinib—pancreatic cancer	0.000487	0.0041	CcSEcCtD
Methimazole—Body temperature increased—Irinotecan—pancreatic cancer	0.000462	0.00389	CcSEcCtD
Methimazole—Vomiting—Sunitinib—pancreatic cancer	0.000451	0.0038	CcSEcCtD
Methimazole—Body temperature increased—Gemcitabine—pancreatic cancer	0.00045	0.00379	CcSEcCtD
Methimazole—Rash—Sunitinib—pancreatic cancer	0.000447	0.00377	CcSEcCtD
Methimazole—Dermatitis—Sunitinib—pancreatic cancer	0.000447	0.00376	CcSEcCtD
Methimazole—Urticaria—Fluorouracil—pancreatic cancer	0.000444	0.00374	CcSEcCtD
Methimazole—Headache—Sunitinib—pancreatic cancer	0.000444	0.00374	CcSEcCtD
Methimazole—Leukopenia—Docetaxel—pancreatic cancer	0.000443	0.00373	CcSEcCtD
Methimazole—Body temperature increased—Fluorouracil—pancreatic cancer	0.000442	0.00373	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—pancreatic cancer	0.000427	0.0036	CcSEcCtD
Methimazole—Arthralgia—Docetaxel—pancreatic cancer	0.000421	0.00355	CcSEcCtD
Methimazole—Myalgia—Docetaxel—pancreatic cancer	0.000421	0.00355	CcSEcCtD
Methimazole—Nausea—Sunitinib—pancreatic cancer	0.000421	0.00355	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000419	0.00353	CcSEcCtD
Methimazole—Jaundice—Epirubicin—pancreatic cancer	0.000416	0.00351	CcSEcCtD
Methimazole—Oedema—Docetaxel—pancreatic cancer	0.000404	0.0034	CcSEcCtD
Methimazole—Pruritus—Gemcitabine—pancreatic cancer	0.000403	0.00339	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000399	0.00336	CcSEcCtD
Methimazole—Pruritus—Fluorouracil—pancreatic cancer	0.000396	0.00333	CcSEcCtD
Methimazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000395	0.00333	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—pancreatic cancer	0.000395	0.00333	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000387	0.00326	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—pancreatic cancer	0.000385	0.00324	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—pancreatic cancer	0.000383	0.00323	CcSEcCtD
Methimazole—Vomiting—Irinotecan—pancreatic cancer	0.000371	0.00313	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000369	0.00311	CcSEcCtD
Methimazole—Rash—Irinotecan—pancreatic cancer	0.000368	0.0031	CcSEcCtD
Methimazole—Dermatitis—Irinotecan—pancreatic cancer	0.000368	0.0031	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000368	0.0031	CcSEcCtD
Methimazole—Headache—Irinotecan—pancreatic cancer	0.000366	0.00308	CcSEcCtD
Methimazole—Paraesthesia—Docetaxel—pancreatic cancer	0.000363	0.00305	CcSEcCtD
Methimazole—Vomiting—Gemcitabine—pancreatic cancer	0.000362	0.00305	CcSEcCtD
Methimazole—Somnolence—Docetaxel—pancreatic cancer	0.000359	0.00302	CcSEcCtD
Methimazole—Rash—Gemcitabine—pancreatic cancer	0.000359	0.00302	CcSEcCtD
Methimazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000358	0.00302	CcSEcCtD
Methimazole—Headache—Gemcitabine—pancreatic cancer	0.000356	0.003	CcSEcCtD
Methimazole—Vomiting—Fluorouracil—pancreatic cancer	0.000356	0.003	CcSEcCtD
Methimazole—Dyspepsia—Docetaxel—pancreatic cancer	0.000355	0.00299	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—pancreatic cancer	0.000355	0.00299	CcSEcCtD
Methimazole—Rash—Fluorouracil—pancreatic cancer	0.000353	0.00297	CcSEcCtD
Methimazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000352	0.00297	CcSEcCtD
Methimazole—Headache—Fluorouracil—pancreatic cancer	0.000351	0.00295	CcSEcCtD
Methimazole—Nausea—Irinotecan—pancreatic cancer	0.000347	0.00292	CcSEcCtD
Methimazole—Alopecia—Epirubicin—pancreatic cancer	0.000339	0.00285	CcSEcCtD
Methimazole—Nausea—Gemcitabine—pancreatic cancer	0.000338	0.00285	CcSEcCtD
Methimazole—Nausea—Fluorouracil—pancreatic cancer	0.000332	0.0028	CcSEcCtD
Methimazole—Body temperature increased—Docetaxel—pancreatic cancer	0.000319	0.00269	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—pancreatic cancer	0.000313	0.00264	CcSEcCtD
Methimazole—Vertigo—Epirubicin—pancreatic cancer	0.0003	0.00253	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—pancreatic cancer	0.000299	0.00252	CcSEcCtD
Methimazole—Pruritus—Docetaxel—pancreatic cancer	0.000286	0.00241	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—pancreatic cancer	0.000284	0.00239	CcSEcCtD
Methimazole—Myalgia—Epirubicin—pancreatic cancer	0.000284	0.00239	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—pancreatic cancer	0.000277	0.00234	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—pancreatic cancer	0.000276	0.00233	CcSEcCtD
Methimazole—Oedema—Epirubicin—pancreatic cancer	0.000272	0.00229	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000267	0.00225	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—pancreatic cancer	0.000263	0.00221	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—pancreatic cancer	0.000263	0.00221	CcSEcCtD
Methimazole—Vomiting—Docetaxel—pancreatic cancer	0.000257	0.00216	CcSEcCtD
Methimazole—Rash—Docetaxel—pancreatic cancer	0.000255	0.00214	CcSEcCtD
Methimazole—Dermatitis—Docetaxel—pancreatic cancer	0.000254	0.00214	CcSEcCtD
Methimazole—Headache—Docetaxel—pancreatic cancer	0.000253	0.00213	CcSEcCtD
Methimazole—Oedema—Doxorubicin—pancreatic cancer	0.000252	0.00212	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000248	0.00209	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000247	0.00208	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—pancreatic cancer	0.000245	0.00206	CcSEcCtD
Methimazole—Somnolence—Epirubicin—pancreatic cancer	0.000242	0.00204	CcSEcCtD
Methimazole—Nausea—Docetaxel—pancreatic cancer	0.00024	0.00202	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—pancreatic cancer	0.00024	0.00202	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00023	0.00193	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—pancreatic cancer	0.000226	0.00191	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—pancreatic cancer	0.000224	0.00189	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—pancreatic cancer	0.000222	0.00187	CcSEcCtD
Methimazole—Urticaria—Epirubicin—pancreatic cancer	0.000216	0.00182	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—pancreatic cancer	0.000215	0.00181	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—pancreatic cancer	0.0002	0.00169	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—pancreatic cancer	0.000199	0.00168	CcSEcCtD
Methimazole—Pruritus—Epirubicin—pancreatic cancer	0.000193	0.00162	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—pancreatic cancer	0.000178	0.0015	CcSEcCtD
Methimazole—Vomiting—Epirubicin—pancreatic cancer	0.000173	0.00146	CcSEcCtD
Methimazole—Rash—Epirubicin—pancreatic cancer	0.000172	0.00145	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—pancreatic cancer	0.000172	0.00145	CcSEcCtD
Methimazole—Headache—Epirubicin—pancreatic cancer	0.000171	0.00144	CcSEcCtD
Methimazole—Nausea—Epirubicin—pancreatic cancer	0.000162	0.00136	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—pancreatic cancer	0.00016	0.00135	CcSEcCtD
Methimazole—Rash—Doxorubicin—pancreatic cancer	0.000159	0.00134	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—pancreatic cancer	0.000159	0.00134	CcSEcCtD
Methimazole—Headache—Doxorubicin—pancreatic cancer	0.000158	0.00133	CcSEcCtD
Methimazole—Nausea—Doxorubicin—pancreatic cancer	0.00015	0.00126	CcSEcCtD
